Insulin resistance, the key defect in type 2 diabetes (T2D), is associated with a low capacity to adapt fuel oxidation to fuel availability, i.e., metabolic inflexibility. This, in turn, contributes to a further damage of insulin signaling. Effectiveness of T2D treatment depends in large part on the improvement of insulin sensitivity and metabolic adaptability of the muscle, the main site of whole-body glucose utilization. We have shown previously in mice fed an obesogenic high-fat diet that a combined use of n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) and thiazolidinediones (TZDs), anti-diabetic drugs, preserved metabolic health and synergistically improved muscle insulin sensitivity. We investigated here whether n-3 LC-PUFA could elicit additive beneficial effects on metabolic flexibility when combined with a TZD drug rosiglitazone. Adult male C57BL/6N mice were fed an obesogenic corn oil-based high-fat diet (cHF) for 8 weeks, or randomly assigned to various interventions: cHF with n-3 LC-PUFA concentrate replacing 15% of dietary lipids (cHF+F), cHF with 10 mg rosiglitazone/kg diet (cHF+ROSI), cHF+F+ROSI, or chow-fed. Indirect calorimetry demonstrated superior preservation of metabolic flexibility to carbohydrates in response to the combined intervention. Metabolomic and gene expression analyses in the muscle suggested distinct and complementary effects of the interventions, with n-3 LC-PUFA supporting complete oxidation of fatty acids in mitochondria and the combination with n-3 LC-PUFA and rosiglitazone augmenting insulin sensitivity by the modulation of branched-chain amino acid metabolism. These beneficial metabolic effects were associated with the activation of the switch between glycolytic and oxidative muscle fibers, especially in the cHF+F+ROSI mice. Our results further support the idea that the combined use of n-3 LC-PUFA and TZDs could improve the efficacy of the therapy of obese and diabetic patients.

Department of Adipose Tissue Biology Institute of Physiology Academy of Sciences of the Czech Republic v v i Prague Czech Republic

Zobrazit více v PubMed

Bays HE, Maki KC, McKenney J, Snipes R, Meadowcroft A, et al. (2010) Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients. Curr Med Res Opin 26: 907–915. PubMed

Reyes-Soffer G, Rondon-Clavo C, Ginsberg HN (2011) Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus. Expert Opin Pharmacother 12: 1429–1438. PubMed

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, et al. (2008) Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia 51: 8–11. PubMed

Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369: 1090–1098. PubMed

Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, et al. (1997) Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46: 701–710. PubMed PMC

MacLean CH, Mojica WA, Morton SC, Pencharz J, Hasenfeld Garland R, et al... (2004) Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythrematosus, and osteoporosis. Summary, Evidence Report. AHRQ Publication No.04-E012–1. PubMed PMC

Nettleton JA, Katz R (2005) n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 105: 428–440. PubMed

Kromhout D, Geleijnse JM, de Goede J, Oude Griep LM, Mulder BJ, et al. (2011) n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. Diabetes Care 34: 2515–2520. PubMed PMC

Ruxton CH, Reed SC, Simpson MJ, Millington KJ (2007) The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 17: 449–459. PubMed

Flachs P, Rossmeisl M, Bryhn M, Kopecky J (2009) Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clinical Sciences 116: 1–16. PubMed

Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H, et al. (1996) High-fat diet-induced hyperglycemia and obesity in mice: Differential effects of dietary oils. Metabolism 45: 1539–1546. PubMed

Ruzickova J, Rossmeisl M, Prazak T, Flachs P, Sponarova J, et al. (2004) Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39: 1177–1185. PubMed

Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, et al. (2005) Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 48: 2365–2375. PubMed

Kuda O, Jelenik T, Jilkova Z, Flachs P, Rossmeisl M, et al. (2009) n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 52: 941–951. PubMed

Sato A, Kawano H, Notsu T, Ohta M, Nakakuki M, et al. (2010) Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 59: 2495–2504. PubMed PMC

Hill JO, Peters JC, Lin D, Yakubu F, Greene H, et al. (1993) Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord 17: 223–236. PubMed

Belzung F, Raclot T, Groscolas R (1993) Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol 264: R1111–R1118. PubMed

Raclot T, Groscolas R, Langin D, Ferre P (1997) Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 38: 1963–1972. PubMed

Flachs P, Ruhl R, Hensler M, Janovska P, Zouhar P, et al. (2011) Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. Diabetologia 54: 2626–2638. PubMed

Hensler M, Bardova K, Jilkova ZM, Wahli W, Meztger D, et al. (2011) The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice. Lipids Health Dis 10: 128. PubMed PMC

Jelenik T, Rossmeisl M, Kuda O, Jilkova ZM, Medrikova D, et al. (2010) AMP-activated protein kinase {alpha}2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids. Diabetes 59: 2737–2746. PubMed PMC

van Schothorst EM, Flachs P, Franssen-van Hal NL, Kuda O, Bunschoten A, et al. (2009) Induction of lipid oxidation by polyunsaturated fatty acids of marine origin in small intestine of mice fed a high-fat diet. BMC Genomics 10: 110. PubMed PMC

Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, et al. (1999) Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70: 817–825. PubMed

Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F (1997) Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes 21: 637–643. PubMed

Kunesova M, Braunerova R, Hlavaty P, Tvrzicka E, Stankova B, et al. (2006) The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res 55: 63–72. PubMed

Thorsdottir I, Tomasson H, Gunnarsdottir I, Gisladottir E, Kiely M, et al. (2007) Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond) 31: 1560–1566. PubMed

Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, et al. (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond) 30: 1535–1544. PubMed

Munro IA, Garg ML (2012) Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet. Br J Nutr 1–9. PubMed

Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, et al. (1987) Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237: 885–888. PubMed

Neschen S, Morino K, Dong J, Wang-Fischer Y, Cline GW, et al. (2007) n-3 fatty acids preserve insulin sensitivity in vivo in a PPAR{alpha}-dependent manner. Diabetes 56: 1034–1041. PubMed

Jucker BM, Cline GW, Barucci N, Shulman GI (1999) Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. Diabetes 48: 134–140. PubMed

Kus V, Flachs P, Kuda O, Bardova K, Janovska P, et al. (2011) Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet. Plos One 6: e27126. PubMed PMC

Fasching P, Ratheiser K, Waldhausl W, Rohac M, Osterrode W, et al. (1991) Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes 40: 583–589. PubMed

Pelikanova T, Kohout M, Valek J, Kazdova L, Base J (1993) Metabolic effects of omega-3 fatty acids in type 2 (non-insulin-dependent) diabetic patients. Ann N Y Acad Sci 683: 272–278. PubMed

Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49: 677–683. PubMed

Galgani JE, Moro C, Ravussin E (2008) Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 295: E1009–E1017. PubMed PMC

Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, et al. (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7: 45–56. PubMed

Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, et al. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311–326. PubMed PMC

Newgard CB (2012) Interplay between Lipids and Branched-Chain Amino Acids in Development of Insulin Resistance. Cell Metab 15: 606–614. PubMed PMC

Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, et al. (2012) Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia 55: 36–45. PubMed

Kus V, Prazak T, Brauner P, Hensler M, Kuda O, et al. (2008) Induction of muscle thermogenesis by high-fat diet in mice: association with obesity-resistance. Am J Physiol Endocrinol Metab 295: E356–E367. PubMed

Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, et al. (2010) Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring) 18: 1695–1700. PubMed PMC

Kwon HS, Harris RA (2004) Mechanisms responsible for regulation of pyruvate dehydrogenase kinase 4 gene expression. Adv Enzyme Regul 44: 109–121. PubMed

Tillmann H, Stein S, Liehr T, Eschrich K (2000) Structure and chromosomal localization of the human and mouse muscle fructose-1,6-bisphosphatase genes. Gene 247: 241–253. PubMed

James DE, Brown R, Navarro J, Pilch PF (1988) Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature 333: 183–185. PubMed

Hunt MC, Rautanen A, Westin MA, Svensson LT, Alexson SE (2006) Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J 20: 1855–1864. PubMed

McGarry JD, Mills SE, Long CS, Foster DW (1983) Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214: 21–28. PubMed PMC

Todd MK, Watt MJ, Le J, Hevener AL, Turcotte LP (2007) Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance. Am J Physiol Endocrinol Metab 292: E485–E493. PubMed

Schiaffino S (2010) Fibre types in skeletal muscle: a personal account. Acta Physiol (Oxf) 199: 451–463. PubMed

Kischel P, Bastide B, Stevens L, Mounier Y (2001) Expression and functional behavior of troponin C in soleus muscle fibers of rat after hindlimb unloading. J Appl Physiol 90: 1095–1101. PubMed

Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, et al. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797–801. PubMed

Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, et al. (2003) Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes 52: 2874–2881. PubMed

Arnold C, Konkel A, Fischer R, Schunck W-H (2010) Cytochrome P-450-dependent metabolism of omega 6 and omega-3 long-chain polyunsaturated fatty acids. Pharmacological Reports 62: 536–547. PubMed

Corpeleijn E, Mensink M, Kooi ME, Roekaerts PM, Saris WH, et al. (2008) Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity (Silver Spring) 16: 1025–1032. PubMed

Rustan AC, Hustvedt BE, Drevon CA (1993) Dietary supplementation of very long-chain n-3 fatty acids decreases whole body lipid utilization in the rat. J Lipid Res 34: 1299–1309. PubMed

Asterholm IW, Scherer PE (2010) Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 176: 1364–1376. PubMed PMC

Hsiao G, Chapman J, Ofrecio JM, Wilkes J, Resnik JL, et al. (2011) Multi-tissue, selective PPARgamma modulation of insulin sensitivity and metabolic pathways in obese rats. Am J Physiol Endocrinol Metab 300: E164–E174. PubMed PMC

An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, et al. (2004) Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 10: 268–274. PubMed

Adams SH (2011) Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Advances in Nutrition 2: 445–456. PubMed PMC

Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, et al. (2010) alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE 5: e10883. PubMed PMC

Lee YS, Li P, Huh JY, Hwang IJ, Lu M, et al. (2011) Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 60: 2474–2483. PubMed PMC

Varma V, Yao-Borengasser A, Rasouli N, Nolen GT, Phanavanh B, et al. (2009) Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 296: E1300–E1310. PubMed PMC

Han MS, Lim YM, Quan W, Kim JR, Chung KW, et al. (2011) Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res 52: 1234–1246. PubMed PMC

Illig T, Gieger C, Zhai G, Romisch-Margl W, Wang-Sattler R, et al. (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42: 137–141. PubMed PMC

Blachnio-Zabielska A, Zabielski P, Baranowski M, Gorski J (2011) Aerobic training in rats increases skeletal muscle sphingomyelinase and serine palmitoyltransferase activity, while decreasing ceramidase activity. Lipids 46: 229–238. PubMed PMC

Baranowski M, Blachnio A, Zabielski P, Gorski J (2007) Pioglitazone induces de novo ceramide synthesis in the rat heart. Prostaglandins Other Lipid Mediat 83: 99–111. PubMed

Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, et al. (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17: 55–63. PubMed PMC

Coen PM, Dube JJ, Amati F, Stefanovic-Racic M, Ferrell RE, et al. (2010) Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 59: 80–88. PubMed PMC

Schmitz-Peiffer C, Biden TJ (2008) Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes. Diabetes 57: 1774–1783. PubMed PMC

Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852–871. PubMed PMC

Szendroedi J, Roden M (2008) Mitochondrial fitness and insulin sensitivity in humans. Diabetologia 51: 2155–2167. PubMed

Essen B, Jansson E, Henriksson J, Taylor AW, Saltin B (1975) Metabolic characteristics of fibre types in human skeletal muscle. Acta Physiol Scand 95: 153–165. PubMed

Kim HG, Han EH, Jeong HG (2008) Effect of troglitazone on CYP1A1 induction. Toxicology 246: 166–171. PubMed

Zhou GD, Zhu H, Phillips TD, Wang J, Wang SZ, et al. (2011) Effects of Dietary Fish Oil on the Depletion of Carcinogenic PAH-DNA Adduct Levels in the Liver of B6C3F1 Mouse. Plos One 6: e26589. PubMed PMC

Romisch-Margl W, Prehn C, Bogumil R, Rohring C, Suhre K, et al. (2012) Procedure for tissue sample preparation and metabolite extraction for high-troughput targeted metabolomics. Metabolomics 8: 133–142.

van Helden YG, Godschalk RW, Heil SG, Bunschoten A, Hessel S, et al. (2010) Downregulation of Fzd6 and Cthrc1 and upregulation of olfactory receptors and protocadherins by dietary beta-carotene in lungs of Bcmo1−/− mice. Carcinogenesis 31: 1329–1337. PubMed

Additive Effects of Omega-3 Fatty Acids and Thiazolidinediones in Mice Fed a High-Fat Diet: Triacylglycerol/Fatty Acid Cycling in Adipose Tissue

Omega-3 Phospholipids from Krill Oil Enhance Intestinal Fatty Acid Oxidation More Effectively than Omega-3 Triacylglycerols in High-Fat Diet-Fed Obese Mice

Reduced Number of Adipose Lineage and Endothelial Cells in Epididymal fat in Response to Omega-3 PUFA in Mice Fed High-Fat Diet

Plasma Acylcarnitines and Amino Acid Levels As an Early Complex Biomarker of Propensity to High-Fat Diet-Induced Obesity in Mice

Combined intervention with pioglitazone and n-3 fatty acids in metformin-treated type 2 diabetic patients: improvement of lipid metabolism

A Difference in Fatty Acid Composition of Isocaloric High-Fat Diets Alters Metabolic Flexibility in Male C57BL/6JOlaHsd Mice

Adipose tissue-related proteins locally associated with resolution of inflammation in obese mice